Published in Eur J Gastroenterol Hepatol on January 01, 2004
Updates in the pathogenesis, diagnosis and management of ectopic varices. Hepatol Int (2008) 1.97
The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol (2007) 1.23
Recanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approach. Korean J Radiol (2010) 0.97
The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Eur J Gastroenterol Hepatol (2004) 0.88
Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon's Point of View. Viszeralmedizin (2014) 0.86
Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center. World J Gastroenterol (2013) 0.83
Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries. Surg Endosc (2009) 0.82
Ruptured Duodenal Varices Successfully Managed by Endoscopic N-butyl-2-cyanoacrylate Injection. J Clin Med Res (2012) 0.78
Percutaneous rheolytic mechanical thrombectomy in thrombosed direct intrahepatic portosystemic shunt: Report of two cases. Interv Med Appl Sci (2015) 0.77
Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut (2006) 0.77
Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant. HPB (Oxford) (2013) 0.75
Recurrent thrombotic occlusion of a transjugular intrahepatic portosystemic stent-shunt due to activated protein C resistance. World J Gastroenterol (2005) 0.75
Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol (2016) 0.75
Acute TIPS occlusion due to iatrogenic arteriovenous shunt in a cirrhotic patient with total portal vein thrombosis. Interv Med Appl Sci (2015) 0.75
Hepatic encephalopathy: you should only comment on what you have actually measured. J Gastroenterol (2009) 0.75
Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results. Eur Radiol (2016) 0.75
An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations. Dig Dis Sci (2017) 0.75
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology (2009) 3.20
Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology (2004) 2.69
Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int (2011) 2.41
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology (2002) 2.17
Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol (2012) 1.91
The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl (2009) 1.80
Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology (2002) 1.60
Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology (2003) 1.59
Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology (2003) 1.55
Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. Eur J Gastroenterol Hepatol (2002) 1.54
Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl (2008) 1.52
Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl (2006) 1.51
Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver Transpl (2005) 1.47
Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol (2007) 1.47
E-cadherin mutation-associated diffuse gastric adenocarcinoma: penetrance and non-penetrance. Eur J Gastroenterol Hepatol (2005) 1.46
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2011) 1.46
Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period. Eur J Gastroenterol Hepatol (2002) 1.41
Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis. Am J Gastroenterol (2004) 1.41
Protein synthesis is severely diminished following a simulated upper GI bleed in patients with cirrhosis. J Hepatol (2008) 1.39
Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes (2008) 1.35
The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord (2008) 1.30
Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. Br J Clin Pharmacol (2011) 1.27
Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology (2004) 1.21
Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol (2006) 1.13
Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol (2004) 1.09
Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl (2004) 1.07
Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4. Ann Saudi Med (2009) 1.06
The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg (2006) 1.05
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04
Hemospray application in nonvariceal upper gastrointestinal bleeding: results of the Survey to Evaluate the Application of Hemospray in the Luminal Tract. J Clin Gastroenterol (2014) 1.03
The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology (2003) 1.02
Endoscopic ultrasound-guided elastography in the nodal staging of oesophageal cancer. World J Gastroenterol (2012) 1.01
Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol (2004) 1.00
Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev (2010) 0.98
Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation (2003) 0.98
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Correlation between hepatitis B surface antigen titers and HBV DNA levels. Saudi J Gastroenterol (2013) 0.96
Cavopulmonary anastomosis without cardiopulmonary bypass. Interact Cardiovasc Thorac Surg (2013) 0.95
Intracardiac extension of metastatic pulmonary leiomyosarcoma. Heart Lung Circ (2005) 0.95
Improvement of C3A cell metabolism for usage in bioartificial liver support systems. J Hepatol (2004) 0.95
Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition. Diabetes (2011) 0.95
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev (2013) 0.95
The natural history of parallel transjugular intrahepatic portosystemic stent shunts using uncovered stent: the role of host-related factors. Liver Int (2006) 0.94
Human thrombin for the treatment of gastric and ectopic varices. World J Gastroenterol (2012) 0.93
Sustained virologic response to peginterferon alpha-2a and ribavirin in 335 patients with chronic hepatitis C: a tertiary care center experience. Saudi J Gastroenterol (2008) 0.93
IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection. Hepatol Int (2013) 0.92
A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases. Hepatol Int (2008) 0.92
Systemic and regional changes in plasma endothelin following transient increase in portal pressure. Liver Transpl (2003) 0.91
Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C. Liver Int (2011) 0.90
The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting. J Clin Virol (2008) 0.89
Low-shear modelled microgravity environment maintains morphology and differentiated functionality of primary porcine hepatocyte cultures. Cells Tissues Organs (2010) 0.88
Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients. Ann Saudi Med (2012) 0.88
Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol (2013) 0.88
Update on risk scoring systems for patients with upper gastrointestinal haemorrhage. World J Gastroenterol (2012) 0.88
Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Transplantation (2004) 0.88
The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. J Hepatol (2010) 0.88
1H NMR spectroscopy as a tool to evaluate key metabolic functions of primary porcine hepatocytes after cryopreservation. NMR Biomed (2002) 0.87
Bio-enteric intragastric balloon in obese patients: a retrospective analysis of King Faisal Specialist Hospital experience. Obes Surg (2008) 0.87
Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis. Liver Int (2012) 0.86
Acute upper gastrointestinal bleeding in the elderly: aetiology, diagnosis and treatment. Drugs Aging (2012) 0.86
The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation. Eur J Gastroenterol Hepatol (2005) 0.86
Development of an invasively monitored porcine model of acetaminophen-induced acute liver failure. BMC Gastroenterol (2010) 0.85
Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis. Eur J Gastroenterol Hepatol (2007) 0.85
Considering adult living donor liver transplantation: a qualitative study of patients and their potential donors. Psychol Health (2010) 0.84
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland. Eur J Gastroenterol Hepatol (2012) 0.84
Increasing organ donation via anticipated regret (INORDAR): protocol for a randomised controlled trial. BMC Public Health (2012) 0.84
Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection. Saudi J Gastroenterol (2011) 0.84
Smoking-related morbidity and mortality following liver transplantation. Liver Transpl (2008) 0.84
Beta-blockers in portal hypertension: new developments and controversies. Liver Int (2013) 0.84
Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology (2004) 0.84
Functional outcome following liver transplantation - a pilot study. Psychol Health Med (2008) 0.83
The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection. Rambam Maimonides Med J (2010) 0.83
Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro. Sci Rep (2013) 0.83
Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol (2006) 0.83
Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl (2002) 0.83
Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Thromb Res (2007) 0.83
Coffee and the liver: a potential treatment for liver disease? Eur J Gastroenterol Hepatol (2010) 0.82
Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy. Trop Gastroenterol (2010) 0.82
The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. Eur J Gastroenterol Hepatol (2008) 0.81
Effect of major liver resection on hepatic ureagenesis in humans. Am J Physiol Gastrointest Liver Physiol (2007) 0.81
Update of endoscopy in liver disease: more than just treating varices. World J Gastroenterol (2012) 0.81
Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series. Eur J Gastroenterol Hepatol (2010) 0.81
The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage. Eur J Gastroenterol Hepatol (2006) 0.80
The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy. Liver Int (2013) 0.80